ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > Beads > LRRC15 > MBS-K079

Human LRRC15-coupled Magnetic Beads

ItemsSize (2mg)Size(2mg X 5)
Particle size2 μm2 μm
Physical appearancePowder mixturePowder mixture
Amount of Coupled Protein≈406 pmol(25.1μg) FAP protein/mg beads≈406 pmol(25.1μg) FAP protein/mg beads
Capacity>133.3 pmol (20μg) Samrotamab /mg beads>133.3 pmol (20μg) Samrotamab /mg beads
FormulationPBS, pH7.4,with 10% TrehalosePBS, pH7.4,with 10% Trehalose
Reconstitution2mL ultrapure water (1 mg beads/mL)2mL ultrapure water (1 mg beads/mL)
  • Background
    LRRC15 (Leucine-rich repeat-containing protein 15) is also known as LIB and hLib. LRRC15 is highly expressed in a variety of solid tumors. LRRC15 was expressed on stromal fibroblasts in many solid tumors (e.g., breast, head and neck, lung, pancreatic) as well as directly on a subset of cancer cells of mesenchymal origin (e.g., sarcoma, melanoma, glioblastoma). LRRC15 expression was induced by TGFβ on activated fibroblasts (αSMA+) and on mesenchymal stem cells. These collective findings suggested LRRC15 as a novel CAF and mesenchymal marker with utility as a therapeutic target for the treatment of cancers with LRRC15-positive stromal desmoplasia or cancers of mesenchymal origin. ABBV-085 is a monomethyl auristatin E (MMAE)-containing antibody–drug conjugate (ADC) directed against LRRC15, and it demonstrated robust preclinical efficacy against LRRC15 stromal-positive/cancer-negative, and LRRC15 cancer-positive models as a monotherapy, or in combination with standard-of-care therapies.
  • Application
    This product is labeled by APC and coupled by CD47 protein in advance, no need to use fluorescent labeled secondary antibody, easy to flow cytometry.
    *The Isotype control (Cat. No. SMB-B01) is sold separately.
  • Reconstitution

    See Certificate of Analysis (CoA) for detailed instruction.

  • Storage
    Store beads at 2° to 8°C and protected from direct light. Do not use after the expiration date shown on the label.Please avoid more than 3 freeze-thaw cycles. Immediate use after reconstitution is highly recommended.
  • Formulation

    Please contact us for detailed information.

    Contact us for customized product form or formulation.

Typical Data
 LRRC15 TYPICAL DATA

Immobilized 25.1μg Biotinylated Human LRRC15 protein to 1mg Beads can bind the Samrotamab with an EC50 of 0.18 μg/mL (QC tested).

  • Clinical and Translational Updates

コメント (0)


ETD of in-stock products: 4 business days

価格(JPY) : Inquire

価格(JPY) : Inquire

プロモーション&展示



医薬品開発状況

  • Number of Launched Drugs:0 Details
  • Number of Drugs in Clinical Trials:0 Details
  • Latest Research Phase:Preclinical

データシート&ドキュメンテーション

DMF請求
DMF (Drug Master File)

関連製品一覧

新製品

お問い合わせ&コメント

This web search service is supported by Google Inc.

totopphone